Welcome to LookChem.com Sign In|Join Free
  • or
Eprosartan related compound C is a chemical compound that is structurally related to eprosartan, an angiotensin II receptor antagonist. It is likely to share similar pharmacological and biological properties with eprosartan, potentially acting by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict.
Used in Pharmaceutical Industry:
Eprosartan related compound C is used as a potential therapeutic agent for the treatment of conditions such as hypertension and heart failure. It functions by helping to lower blood pressure and reduce the strain on the heart, similar to eprosartan.
Further research is needed to fully understand the potential therapeutic uses and mechanisms of action of eprosartan related compound C.

4475-24-5

Post Buying Request

4475-24-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4475-24-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4475-24-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,4,7 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4475-24:
(6*4)+(5*4)+(4*7)+(3*5)+(2*2)+(1*4)=95
95 % 10 = 5
So 4475-24-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H8O4S/c9-7(10)6(8(11)12)4-5-2-1-3-13-5/h1-3,6H,4H2,(H,9,10)(H,11,12)

4475-24-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1238240)  Eprosartan Related Compound C  United States Pharmacopeia (USP) Reference Standard

  • 4475-24-5

  • 1238240-25MG

  • 13,501.80CNY

  • Detail

4475-24-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(thiophen-2-ylmethyl)propanedioic acid

1.2 Other means of identification

Product number -
Other names thien-2-ylmethyl-malonic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4475-24-5 SDS

4475-24-5Relevant academic research and scientific papers

METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt

-

Paragraph 0387; 0388; 0425; 0426, (2014/05/07)

The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

PHOSPHINIC ACID DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY

-

, (2008/06/13)

Compounds of formula (I) wherein R, R1, R2, R3, R4 and n have the meanings reported in the description are described. The compounds of formula I are endowed with a dual ACE-inhibitory and NEP-inhibitory activity and are useful in the treatment of cardiovascular diseases.

PHOSPHINIC ACID DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY

-

, (2008/06/13)

Compounds of formula STR1 wherein R, R 1, R 2, R. sub.3, R. sub.4 and n have the meanings reported in the description are described. The compounds of formula I are endowed with a dual ACE-inhibitory and NEP-inhibitory activity and are useful in the treatment of cardiovascular diseases.

N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity

-

, (2008/06/13)

Angiotensin II receptor antagonists having the formula: STR1 which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4475-24-5